Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device
6th Apr 2006, 20:05 GMT
Implanted drug delivery systems are being increasingly used to realize the therapeutic potential of peptides and proteins. Here we describe the controlled pulsatile release of the polypeptide leuprolide from microchip implants over 6 months in dogs. Each microchip contains an array of discrete reservoirs from which dose delivery can be controlled by telemetry.
Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device related news:
- Implanted Chip Opens New Doors — RedOrbit News - Technology
- DOD Awards Microchip Biotechnologies SBIR Phase II for Biodefense Device — PR Newswire: All Releases
- pSivida Signs New Evaluation Agreement for Cardiovascular Drug Delivery — RedOrbit News - Health
- Analysis: Anti-stroke device improves memory — United Press International - Health Business
- Sony and Borders to Sell Digital Reading Device — EContent RSS Feeds : Research Center: Content Delivery
- New device allows woman to see, even without eyes — KurzweilAI.net Accelerating Intelligence News
- Surgically Implanted RFID — WebProNews: Combined RSS Feed
- Replacing Your ICD — Your Healthy Heart
- Genesis Microchip to Miss Guidance — NGSP
- Ferromagnetism in 200-MeV Ag[sup +15]-ion-irradiated Co-implanted ZnO thin films — Applied Physics Letters: All Topics